InvestInfoAI
Whitefort Capital Management, LP

Q4 2025 · 13F-HR

Whitefort Capital Management, LPholdings as filed

Filed 2026-02-17 · accession 0001013594-26-000254

$391.2M
Reported value
20
Positions
2025-12-31
Period end
View analyzed profile →PRO

The Brief · Whitefort Capital Management, LP · Q4 2025

AI · grounded in 13F

Whitefort Capital Management, LP exited its position in SPY, reducing exposure by $26.6M. The fund established new positions in MRNA for $29.5M, SOC for $17.2M, and QURE for $11M. Additionally, the fund closed its position in IWM and increased its holdings in BALY by 43%.

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
03879J100ABUSARBUTUS BIOPHARMA CORP$64.2M16.4%13,343,228CommonSOLE
G76279101ROIVROIVANT SCIENCES LTD$46.0M11.8%2,120,000CommonSOLE
05875B304BALYBALLYS CORPORATION$31.7M8.11%1,921,372CommonSOLE
60770K107MRNAMODERNA INC$29.5M7.54%1,000,000PUTSOLE
68218J103OABIOMNIAB INC$26.3M6.73%14,223,658CommonSOLE
46591M109JOYYJOYY INC$26.2M6.70%404,944CommonSOLE
36472T109TDAYUSA TODAY CO INC$24.6M6.29%4,774,833CommonSOLE
37247D106GNWGENWORTH FINL INC$22.9M5.86%2,540,301CommonSOLE
127537207CDZICADIZ INC$22.4M5.72%3,986,822CommonSOLE
53635D202LQDALIQUIDIA CORPORATION$20.5M5.24%594,700CALLSOLE
78574H104SOCSABLE OFFSHORE CORP$17.2M4.41%1,910,793CommonSOLE
68375NAG8OPK 3.75 01/15/29OPKO HEALTH INC$12.5M3.19%9,350,000CommonSOLE
N90064101QUREUNIQURE NV$11.0M2.81%459,000CommonSOLE
78463V107GLDSPDR GOLD TR$10.7M2.74%27,000CALLSOLE
86881A100SGRYSURGERY PARTNERS INC$9.3M2.37%600,000CommonSOLE
53635D202LQDALIQUIDIA CORPORATION$5.4M1.39%158,000CommonSOLE
68375N103OPKOPKO HEALTH INC$5.4M1.37%4,253,340CommonSOLE
45784J303VATEINNOVATE CORP$3.4M0.86%743,000CommonSOLE
G5260K102KGKESTREL GROUP LTD$1.6M0.42%160,916CommonSOLE
65345N114NNAVWNEXTNAV INC$337,9380.09%47,264CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.